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A B S T R A C T
Discussions whether hypoalbuminemia is just a marker for the malnutrition-inflammation syndrome as well as for
the increased morbidity and mortality of those patients or is it an etiological factor, are becoming more and more intense.
In this research of the relation between hypoalbuminemia and the complications that threaten the vascular access with
special reference to infection, and consequently to the life of the patients treated with chronic haemodialysis, we have cho-
sen 120 patients with terminal renal insufficiency (ESRD) treated at the Clinical Hospital Mostar by chronic haemo-
dialysis. The chosen patients for this study were observed throughout a time period of 18 months. Only the patients who,
at the moment of starting the research did not exhibit either a local or a systemic infection, as well as no signs of any
other complication that might have endangered the vascular access and consequently the life of the patient, were selected.
From the 120 (100.0%) patients, 86.8% of them had a serum albumin level below 40,0 g/L. By analysing the research re-
sults of the clinical material, it has been established that in patients with serum albumin level below 40.0 g/L, the infec-
tion incidence was significantly higher than in those patients with the albumin level above 40.0 g/L (c2 = 7.215 P =
0.0077). The complication incidence is significantly higher (c2 = 9.92 P = 0.0022) among the patients with serum albu-
min level below 40.0 g/L, than in those patients with higher serum level. Among the patients with a serum albumin level
lower than 40,0 g/L, the sepses incidence was significantly higher (c2 = 4.77 P 0.03), than among those patients with a
serum albumin level above this value. However, the difference in incidence of local infection of the vascular access be-
tween the group of patients with a serum albumin level below 40.0 g/L and those patients with albumin level above this
value is not significant (c2 = 0.65 P = 0.69). The total infection incidence in the 120 observed patients was 3.8 episodes
per 100 patient months, and within the parameters mentioned by other authors.
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Introduction
The incidence of mortality in patients undergoing the
treatment of chronic haemodialysis is many times higher
than in the rest of population1–7. It has been long noticed
that the morbidity and mortality incidence of dialysed
patients with pronounced hypoalbuminemia is higher
than in those patients with normal serum albumin con-
centration8–10. Recently, the relation between hypoal-
buminemia and the morbidity and mortality of the pa-
tients treated by chronic haemodialysis has become the
subject of more intense research8,10–14. The research is
twofold: 1. establishing the cause of hypoalbuminemia
and 2. determining the possible role of hypoalbuminemia
in the morbidity and mortality. Regarding the latter re-
search point raised, whether hypoalbuminemia in those
patients is just a serological marker of inflammation and
malnutrition as well as the mortality marker, or whether
it is in a cause-effect relation with the higher morbidity
and mortality rate12,15–17, becomes the subject matter.
About 50% of dialysed patients have a serum albumin
concentration lower than 4.0 g/L8. There are two effi-
cient factors that in these patients directly influence the
decrease of the serum albumin concentration in the af-
fected organism, especially in uremic patients: inflam-
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mation and malnutrition18,19,20. These two factors act in
synergy in such a way that the inflammation intensifies
the effect of the malnutrition (the malnutrition-inflam-
mation syndrome)8,10.
In these patients, hypoalbuminemia is in a positive
correlation with the morbidity and mortality1,12,21 and
they are, according to the reported findings of Lowrie et
al.9 and Kaysen et al.22, in 20 times greater death risk
than those patients with a normal serum albumin con-
centration. Khan and Catto23 claim that dialysed pa-
tients with serum albumin concentration between 30.1
and 35.0 g/L, are exposed to 5 times higher death risk
than those patients in which the concentration is be-
tween 40.1 i 45.0 g/L. Powe and associates10 have found
that dialysed patients with an albumin concentration be-
low 3.5 mg/dl, are at a 66% greater risk of septicemia
than those patients with serum albumin higher levels.
Hypoalbuminemia in patients treated with chronic
haemodialysis is in correlation with morbidity and mor-
tality, but also with the inflammation markers such as
proteins of the acute inflammation phase (CRP)24,25,26
and cytokines27, thus sometimes regarding albumin as a
negative protein of the inflammation acute phase1,11,28.
In the majority of dialysed patients death is caused by
cardiovascular disorders1,7,29. Inflammation on dialysed
patients has two effects: hypoalbuminemia and damag-
ing of the endothels’ vascular structures. In the creation
of atheromatous vascular changes, co-morbidity, such as,
diabetes, hyperlipidemia and hypertension9,16, have their
effects, with additional participation of oxidative stress
and endothelial dysfunction of the cardiovascular system
initiated by inflammation30. Stenvinkel et al.28 consider
that inflammation and malnutrition are frequently used
as synonyms for hypoalbuminemia22,31, which work in
synergy in the creation of the conditions for atherosclero-
sis, which would then establish the conditions for in-
creased morbidity and mortality of this population of pa-
tients.
Put forward, as considered by Don and Kaysen12,
points to the fact that the hypoalbuminemia problem in
the patients treated with chronic haemodialysis is more
complex than it is comprehended and is frequently re-
lated to malnutrition in such a way that sometimes mal-
nutrition and hypoalbuminemia are sometimes regarded
as synonyms22,31. The fundamental question that re-
mains to be answered is whether hypoalbuminemia in
dialysed patients is just a serological marker of inflam-
mation and malnutrition (malnutrition – inflammation
complex syndrome) as well as strong marker (predictor)
of mortality, or whether is it in a cause-effect relation
with increased morbidity and mortality8,21. Throughout
our research we wanted to give a contribution to the re-
sponses to the questions risen above.
Patients and Methods
The patients with terminal renal insufficiency have
been treated for 40 years in the Hospital Dialysis Centre
of the Clinical Hospital Mostar by chronic haemodialysis.
In the last decade, the vascular approach in the Clinical
Hospital Mostar has been established on the majority of
patients by using the arteriovenous fistula, primarily on
the upper extremities in the wrist area (Bresci-Cimino
fistulae), and if possible, on the non-dominant arm. The
vascular approach by tetrafluorethylene graft is rarely
established, and the vascular access on the lower extrem-
ities is established as an exception, that is, when all other
possibilities of using upper extremities have been ex-
hausted.
For the purpose of establishing a relation between
hypoalbuminemia and the complication incidence that
endangers vascular access, especially infection, and then
the life of the dialysed person, we have chosen 120 pa-
tients treated through the programme of chronic dialysis
to monitor, who had AV-fistulae established on their fore-
arm. The patients were chosen randomly, and only those
who did not exhibit any signs of local infection of the ar-
teriovenous access or septicemia at the moment of start-
ing the research, as well as no signs of any other compli-
cation which could endanger the vascular access, and
consequently the life of the patients. The patients have
been observed throughout the time period of 18 months
and apart from the blood tests, they were also tested for
the albumin levels in serum at 3 month intervals.
Descriptive statistics has been used in the basic evalu-
ation of the numerical data in order to determine the
mean values of the standard deviation and the span. The
categorical data is shown by the frequency of appear-
ance, as well as its proportion, that is, its percentage. In
the statistical analysis we have used the c2 test. The sta-
tistical significance considered for the level of impor-
tance is P0.05 , that is with a 95% of relevance thresh-
old. For the analysis of the collected data we have used
the application program Statistics, version 8.0 whereas
the graphic presentation has been made in Excel.
Results
The distribution of patients according to age and sex
is shown in table 1, whereas table 2 illustrates the patho-
logical conditions that were the cause of the terminal re-
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TABLE 1
DISTRIBUTION OF PATIENTS ACCORDING TO AGE AND SEX
Age Male Female Total
11–20 – 1 1
21–30 3 – 3
31–40 8 6 14
41–50 10 7 17
51–60 23 13 36
61–70 10 7 17
71–80 15 13 28
81–90 – 3 3
91–100 1 – 1
Total 70 50 120
nal insufficiency (ESRD). On table 2 it can be seen that
the most frequent cause of kidney failure was hyperten-
sive nephrosclerosis, then interstitial nephritis, followed
by glomerulonephritis, whereas other pathological condi-
tions were considerably less represented. Table 3 illus-
trates comorbidity. Some of those comorbidity condi-
tions, such as diabetic nephropathy, as it could be conclu-
ded, contribute as a self-working agent to increased mor-
bidity and mortality of dialysed patients.
Table 4 shows the original places of infection develop-
ment, and then septicemia, as well as the number of pa-
tients with infection. The number of patients in which
the causative agent of infection was isolated, that is, the
type of microorganism, is shown in the right column of
the aforementioned table. Hence, it can be seen that in
some patients with infection the causative agent has not
been isolated. As it is evident from the presented data,
the most frequently present is the respiratory infection
in the patients, the infection of the vascular access area
follows, that is, local infection of the vascular access,
which then, alongside other things mentioned in the ta-
ble, represented the original point of sepses.
The results of requested blood tests indicative to the
observation and treatment of patients treated with chro-
nic haemodialysis, among which are albumins, ferritin as
well as calcium in serum, are illustrated in table 5. The
highest and the lowest levels, as well as the mean value
of the results with standard deviation of all parameters
are presented, and they were established in all patients
included in the research.
The values of serum albumin level and the distribu-
tion of patients according to the relation between those
findings and the infection incidence are illustrated in ta-
ble 6. Among those 48 (100.0%) with an infection, 47
(97.2%) of them had hypoalbuminemia, and only 1 (2.1%)
had serum albumin concentration above 40.0 g/L. The
difference between those two values is 95.1%. From
those 72 (100.0%) patients, 57 (79.2%) had a serum albu-
min level below 40.0 g/L, and 15 (20.8%) above this level.
The difference between these two values is 58. 4%.
The research results of the ratio of patients with an
albumin level below 40.0 g/L and those above the afore-
mentioned value among the patients with an infection
are 95.1. This ratio among the patients without an infec-
tion is 58.4. These two results illustrate the relation be-
tween hypoalbuminemia and an infection in patients
treated with chronic haemodialysis. The difference be-
tween the aforementioned two values, that is, 95.1 and
58.4 is 36.7, and shows the relation between hypoalbu-
minemia and the infection incidence in the patients. It is
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TABLE 2
PATHOLOGICAL CONDITIONS WHICH CAUSED TERMINAL KID-
NEY FAILURE (ESRD)











THE INCIDENCE OF CONCOMITANT DISEASES
Comorbidity Number of patients %





THE ILLUSTRATION OF THE PRIMARY SPOT OF INFECTION AND THE KINDS OF ISOLATED MICROORGANISMS IN
HYPOALBUMINEMIC PATIENTS WITH INFECTION
Primary spot of infection Number of patients Isolated microorganisms Number of patients with microorganism %
Vascular access 15 Staphylococcus epidermidis 4 (26.6)
Staphylococcus aureus 6 (40.0)
Infection of respiratory system Streptococcus pneumoniae 1 (6.2)
16 Klebsiella pneumoniae 2 (12.4)
Infectio of urinary system Escherichia coli 3 (3 3.3)
9 Enterococcus species 2 (22.2)
Infectio of skin and soft tissues Streptococcus pypgenes 1 (25.0)
4 Streptococcus aureus 2 (50.0)





Others 2 – – –
evident that there is a significant difference considering
the frequency of infection in patients with the albumin
level in serum < 40 and those > 40 (c2 = 7.215 P =
0.0077).
Table 7 shows the type and complications incidence
that can endanger the vascular access and consequently
the life of a dialysed patient. Throughout the time period
of 18 months of observation 120 (100.0%) patients, 59
(49.16%) of them had complications. Of those 59 (100.0%)
patients with complications, 58 (98.3%) of them, as it can
be seen from table 7, had serum albumin level below 40.0
g/L, that is, they had hypoalbuminemia.
The results of the comparison relation between the al-
bumin level and the complication incidence are pre-
sented in table 7. It is evident that there is a significant
difference regarding the complication frequency in pa-
tients with the serum albumin level < 40 and those > 40
(c2 = 9.92 P = 0.0022).
The patients have been divided into two groups in a
way that one group consisted of those patients with
sepses, and those patients without a single sepses infec-
tion attack were put in the other group (table 8). In the
majority of patients with sepses, as it is evident from the
table, infection was displayed with one episode, and in
only 8 patients two episodes. Table 8 also shows that only
1 (2.5%) out of 40 (100.0%) patients with sepses had a se-
rum albumin level above 40.0 g/L, whereas 39 (97.5%)
patients had a serum albumin level below the aforemen-
tioned value, hence, they had hypoalbuminia. The differ-
ence between these two values in percentages is 95.0%,
which evidently indicates a high association between
hypoalbuminemia and bacteremia. Moreover, out of 80
(100.0%) patients without infection, 65 (81.25%) patients
had a serum albumin level below 40.0 g/L, and 15 (18.75%)
of them above this value. The difference between these
two percentage values is 62.5. In the group of patients
with sepses, the difference in percentages between those
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TABLE 5
RESULTS OF BLOOD TESTS (THE LOWEST, THE HIGHEST AND MIDDLE VALUES AS WELL AS STANDARD DEVIATION) OF VARIABLES
Variable Minimum Maximum Arithmetic mean Standard deviation
Serum proteins g/L 30.6 85.1 63.46 6.93
Serum albumins g/L 20.2 50.1 36.6 3.8
C-reactive proteins mg/L 0.1 191.8 12.31 21.05
Serum feritin µg/L 4.43 111.9 169.05 206.58
Hemoglobin g/dL 59 160 102.61 17.83
Urea prior to dialysis mmol/L 5.2 44 21.3 5.16
Serum calcium mmol/L 5.24 13.12 8.94 0.84
TABLE 6
DISTRIBUTION OF PATIENTS ACCORDING TO THE RELATION BETWEEN THE ALBUMIN LEVEL IN THE SERUM AND INFECTION
INCIDENCE
Albumin level in serum (g/L) Number of patients
with infection without infection Total %
< 30.0 5 – 5 4.17
30.1–35.0 27 2 29 24.17
35.1–40.0 15 55 70 58.33
40.1–45.0 1 15 16 13.33
Total 48 (40.0%) 72 (60.0%) 120 100.0
The results of examinees comparison according to the relation of the albumin level in serum and incidence of infection
TABLE 7













< 30.0 5 – – – – 2 7
30.1–35.0 27 4 – – – – 31
35.1–40.0 15 4 – – 1 – 20
40.1–45.0 1 – – – – – 1
Total 48 (81.36%) 8 (13.56%) 0 0 1 (1.69%) 2 (3.39%) 59 (100.0%)
whose level of serum albumins was below 40.0 g/L and
those with the level above that value is 95.0, and in the
group of patients without sepses, that same difference is
62.5. If those two values, that is, 95.0 and 62.5 are put in
relation, the difference is 32.5 and it is statistically sig-
nificant (c2 = 4.77 P = 0.03), and represents in fact the
index of association of hypoalbuminemia and sepses within
the observed group of patients.
Table 9 also illustrates the relation between the level
of serum albumins and the incidence of localised infec-
tion of the vascular access. Out of the 15 (100.0%) pa-
tients with vascular access infection, 14 (93.34%) of them
had a level of serum albumins below 40.0 g/L, and only 1
(6.7%) above that value. The difference between those
two values in percentages is 86,6. On the other hand, out
of the 105 (100.0%) patients without vascular access in-
fection, as it is shown in table 9.90 (85.71%) of them had
a serum concentration of albumins below 40.0 g/L, and
15 (14.28%) above this value. The difference in percent-
ages is 71.43. If we compare the percentages, the differ-
ence between the hypoalbuminemia incidence in the pa-
tients with an infection of the vascular access, and is
86,6, and those without infection is 71.43, the difference
between these two values is 15.17, and it is statistically
insignificant (c2 = 0.165 P = 0.69).
Discussion
It has generally been accepted that malnutrition and
inflammation, used separately and in synergy, are in a
positive correlation with the morbidity and mortality of
dialysed patients31–33. Kaysen et al.21 and Mailloux33 et al.
are of the opinion that malnutrition, and in a consistent
manner, hypoalbuminemia, would not be considered re-
sponsible on their own for increased mortality. Waldman
et al.34 as well as Don and Kaysen12 mention the example
of organisms with analbuminemia that lead a normal life
in spite of their condition. In addition, it has been stated
that the serum albumin level starts to decline much ear-
lier than the organism reaches the state of terminal renal
insufficiency, that is, as early as in the pre-terminal kid-
ney failure phase35. Correspondingly, in the malnutrition
state of an otherwise healthy organism, the serum albu-
min level does not decrease significantly for a longer pe-
riod, yet this basically happens only when in a terminal
phase of severe starvation36.
Our research of dialysed patients went in the direc-
tion of establishing the relation between the low serum
albumin level and the complication incidence, with spe-
cial emphasis made on the infection without special em-
phasis into the research of the hypoalbuminemia oscilla-
tion influence, as it has been monitored by Kalantar-
-Zadeh et al.8. In earlier research we have also observed
those oscillations of serum albumin concentration. In the
majority of monitored patients treated with chronic hae-
modialysis we did not succeed significantly to influence
the stabilisation of the serum albumin level by a pro-
grammed dietetic nutritional regime, although Powe et
al.10, based on their findings, suggest that a systemati-
cally programmed nutrition could influence the improve-
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TABLE 8




Nuber of patients Patients with sepses
with sepses without sepses
infection episodes
1 2
< 30.0 5 – 5 1
30.1–35.0 18 11 18 4
35.1–40.0 16 54 16 3
40.1–45.0 1 15 1 –
Total 40 80 40 8
TABLE 9











< 30.0 1 4 1 –
30.1–35.0 8 21 8 3
35.1–40.0 5 65 5 –
40.1–45.0 1 15 1 –
Total 15 105 15 3
ment of hypoalbuminemia. 86% of our patiens had an al-
bumin concentration below 40.0 g/L (table 6). Based on
experience, this serum albumin concentration was set as
a limit as the boundary of determining hypoalbumi-
nemia, and in such respect out views almost concurred
with those of Kalantar-Zadeha and al.8, whereas Powe
and al.10, Held and al.37 as well as Bergström and al.38, set
a somewhat lower hypoalbuminemia level while resear-
ching mortality risk factors.
The hypoalbuminemia incidence difference in per-
centages among patients with an infection and those
without infection as viewed from table 6, is 36.7% and it
is statistically significant. This finding regarding the pa-
tients treated with chronic haemodialysis could hardy re-
main being interpreted simply as malnutrition and in-
flammation markers and morbidity and mortality predic-
tors. Established in a very close relation to hypoalbu-
minemia observation on the one hand and inflammation
on the other hand imposes a further intensive expert-sci-
entific research in the direction of determining the cau-
sality of such a relation and parameters. It is to be ex-
pected, especially through an intensive investigation of
the ways by which hypoalbuminemia significantly influ-
ences the increase of infection incidence, which is accom-
panied by a really high morbidity and mortality rate of
dialysed patients.
In the group of 120 (100.0%) examinees included in
this study, threatening complications were displayed in
59 (49.2%) of them (table 7), although in an earlier re-
search it was found that the incidence of threatening
complications in our patients was ranging at somewhat
lower values39. Out of those 59 (100.0%) patients with
complications, 48 (81.35%) of them exhibited an infec-
tion as a complication. Out of these 48 (100.0%) patients
with an infection, 47 (97.2%) had a serum albumin level
below 40.0 g/L as a complication, and only 1 (2.1%) above
this value. This parameter indicates a high association of
hypoalbuminemia and the complication occurrence, es-
pecially infection.
Table 8 shows patients divided into two groups: one
group is comprised of the patients who had a sepses epi-
sode and the other group the ones without sepses. Sepa-
rated in such a way, that is, divided according to the crite-
ria of septic infection, they are also divided according to
the serum albumin concentration level. The aforemen-
tioned table illustrates that 39 (97.5%) out of 40 (100.0%)
patients with sepses had a serum albumin level below
40,0 g/L, that is, they had hypoalbuminemia, and only 1
(2.5%) of them above this level. The difference in per-
centages is 95.0, and it expressed the hypoalbuminemia
ratio in the patients with sepses. Out of 80 (100.0%) of
the patients without sepses, 65 (81.25%) of them had se-
rum albumin level below 40.0 g/L and 15 (18.75%) above
this value. The difference between these two values is
62.5 and it expresses the hypoalbuminemia ratio in pa-
tients without sepses. The calculated hypoalbuminemia
ratio in examinees with sepses, as evident from table 8, is
32.5 and it is statistically significant (P = 0.03), and rep-
resents a relative index of association between hypo-
albuminemia and infection. This finding indicates more
a cause-effect relation of hypoalbuminemia and infection
than it points that hypoalbuminemia could be only an in-
flammation and malnutrition marker, as well as a possi-
ble mortality predictor.
Among the patients with an infection of the vascular
access (Table 9), out of the 15 (100.0%) of them, 14
(93.3%) had a serum albumin level below 40.0, and only
1(6.7%) had higher than this value. The difference be-
tween these two values regarding percentages, that is,
ranging between 93.3% and 6.7%, is 86.6 and it expresses
the hypoalbuminemia ratio in patients with an infection
of the vascular access. On the other hand, out of 105
(100.0%) patients without vascular access infection, as
indicated in table 9, 90 (85.71%) of them had a serum al-
bumin level below 40.0 g/L, and 15 (14.28%) above this
level. The difference between these two values expressed
in percentages is 71.43, and it expresses the hypoalbu-
minemia ratio in patients without a vascular access in-
fection. If put in a relative comparison, the percentage
difference expressed between the hypoalbuminemia inci-
dence in patients with vascular access infection, which is
86.6%, and those in patients without infection, which is
71.43%, is statistically insignificant as the difference be-
tween these two values is 15.17 (P = 0.69). The associa-
tion index between hypoalbuminemia and infection can
also be seen in the research result of this relation, as well
as in the relationship between sepses and hypoalbu-
minemia (table 8). However, we are of the opinion that
the basis of this result is too a small specimen or the time
interval monitored too short. The research result of this
monitored relation also indicated the increased rate of
infection and hypoalbuminemia association.
The total infection incidence of the 120 observed pa-
tients regarding hypoalbuminemia displayed the usual
3.8 episodes on 100 patients months. This finding fits the
research results of other authors in which the infection
incidence ranges from 0.7 to 7.0 episodes per 100 pa-
tients months. In such respect, Kessler et al.40 had 0.7,
Hoen et al.41 0.9 and Tokars et al.42 3.5 episodes of infec-
tion per 100 patients months.
At the end of the programmed research of clinical
causatives encompassed in this study, the following re-
sults can be illustrated:
1. 86.6% of patients had a serum albumin concentration
below 40.0 g/L,
2. out of 120 (100.0%) patients, 59 (49.16) of them had at
least one possible
complication throughout the observation period,
3. out of 59 (100.0%) patients with complications, 48
(81.35%) of them had an
Infection,
4. out of 48 (100.0%) patients with an infection, 47
(97.2%) of them had a serum albumin level below 40.0
g/L, that is hypoalbuminemia, and out of 72 (100.0%)
without infection, 57 (79.2%) of them had serum albu-
min level below the mentioned value. The difference
in ratios between hypoalbuminemia and infection in
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patients with infection and those patients without in-
fection is 36,7 and it is statistically significant (c2
=7.215 P =0.0077),
5. from the 48 (100.0%) patients with an infection, 40
(83.3%) exhibited sepses
Symptoms,
6. from the 40 (100.0%) patients with sepses, 39 (97.5%)
of them had a serum albumin level below 40.0 g/L,
and out of 80 (100.0%) of those patients without
sepses, 65 of them (81.25%). The difference in ratios
of the relation between hypoalbuminemia and infec-
tions in patients with sepses and those patients with-
out is 32.5 and it is statistically significant (c2 = 4.77
P = 0.03),
7. 93.3%of the patients with a vascular access infection
exhibited a serum albumin level below 40.0 g/L, and
in the group of those patients without local infection
85.71% of them. The difference in ratios between
hypoalbuminemia and a local infection of the vascular
access in patients with an infection and those without
an infection is 15.7 and it is not statistically signifi-
cant (c2 = 0.165 P = 0.69),
8.total infection incidence in all 120 patients is 3.8 epi-
sodes per 100 patients months.
Conclusion
Established and illustrated values clearly prove a high
association of hypoalbuminemia and infection, which de-
mand further comprehensive complex research. This re-
search should find an answer to the continuously re-
peated question, both in the profession and by science,
whether hypoalbuminemia is just a marker of relation
between malnutrition and infection and possibly a pre-
dictor of morbidity and mortality, or is it in a cause-effect
relation with the development of the infection in patients
treated with haemodialysis.
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ODNOS HIPOALBUMINEMIJE I INCIDENCIJE KOMPLIKACIJA U BOLESNIKA NA PROGRAMU
KRONI^NE HEMODIJALIZE LIJE^ENIH U KLINI^KOJ BOLNICI MOSTAR
S A @ E T A K
Hipoalbuminemiju prati povi{eni morbiditet i mortalitet bolesnika lije~enih kroni~nom hemodijalizom. Sve se inten-
zivnije vode rasprave o tome da li je hipoalbuminemija samo marker malnutricija-inflamacija sindroma te predskaziva~
pove}anog morbiditeta i mortaliteta ili je etiolo{ki ~imbenik. Isto se tako sve vi{e istra`uje sinergisti~ko djelovanje
malnutricije i inflamacije na morbiditet i mortalitet ove poulacije bolesnika. No, ni danas nije na|eno adekvatno obja-
{njenje tih fenomena. U ispitivanje odnosa hipoalbuminemije i komplikacija koje ugro`avaju vaskularni pristup s po-
sebnim osvrtom na infekciju, a onda i na `ivot lije~enih kroni~nom hemodijalizom, uzeli smo u obradu 120 bolesnika s
terminalnom renalnom insuficijencijom (ESRD) lije~enih u Klini~koj bolnici Mostar kroni~nom hemodijalizom. Boles-
nici uzeti u obradu u ovoj studiji promatrani su kroz 18 mjeseci. Uzeti su samo oni bolesnici koji u trenutku zapo~i-
njanja ispitivanja nisu imali ni lokalnu niti sistemsku infekciju, a niti znakove neke od komplikacija koje mogu ugroziti
vaskularni pristup, a onda i `ivot bolesnika. Od 120 (100,0%) promatranih ispitanika njih je 86,8% imalo serumsku
razinu albumina ispod 40,0 g/L. Analizom rezultata ispitivanja u obradu uzetog klini~kog materijala utvr|eno je da je u
ispitanika sa serumskom razinom albumina ispod 40,0g/L incidencija infekcije zna~ajno ve}a nego u onih s razinom al-
bumina iznad 40,0 g/L. (c2 = 7,215 P = 0,0077). Incidencija komplikacija zna~ajno je ve}a (c2 = 9,92 P = 0,0022) me|u
ispitanicima s razinom serumskih albumina ispod 40,0 g/L, nego me|u onima s vi{om serumskom razinom. Me|u ispi-
tanicima s razinom albumina u serumu ni`om od 40,0 g/L incidencija sepse je zna~ajno ve}a (c2 = 4,77 P = 0,03), nego
me|u onima sa serumskom razinom albumina iznad te vrijednosti. Me|utim razlika u incidenciji lokalne infekcije
vaskularnog pristupa izme|u grupe ispitanika sa serumskom razinom albumina ispod 40,0 g/L i onih s razinom albu-
mina iznad te vrijednosti nema zna~ajne razlike (c2 = 0,65 P = 0,69). Rezultat ispitivanja ovog parametra, koji ne prati
rezultate ispitivanja gore navedenih parametara, mo`e se shvatiti uvjetno kao ishod pra}enja nedovoljvo velikog broja
ispitanika. Sveukupna incidencija infekcije u 120 promatranih bolesnika iznosi 3,8 epizoda na 100 bolesnikovih mjeseci
{to se nalazi unutar referiranih vrijednosti drugih autora.
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